Patents Assigned to University System of Georgia
-
Patent number: 10335374Abstract: Bacterial resistance to antibiotics is increasing worldwide creating a global threat. Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, is a bacterial infectious disease that results in over one million deaths annually. The discovery outlined here involves a tablet composition for patient administration and subsequently a new paradigm in drug delivery vehicles in vivo and in vitro and is applied to existing TB antibiotics in order to increase their efficacy. The drug delivery system is a three component complex that is administered with the TB antibiotic or a combination of TB antibiotics. The components are a saccharide or saccharides, a transition metal ion or a combination of metal ions that can bind a nitrogen and/or oxygen atom(s), and a water soluble polymer capable of aggregating and enclosing the other constituents. The three component molecular delivery approach has demonstrated ability to overcome M. tuberculosis bacterial resistance to an existing antibiotic.Type: GrantFiled: August 3, 2015Date of Patent: July 2, 2019Assignee: University System of Georgia, Valdosta State UniversityInventors: Thomas J. Manning, Sydney E. B. Plummer, Tess A. Baker
-
Patent number: 9441993Abstract: A system for measuring the superposition of a plurality of sound waves propagating within a conduit containing a fluid having a plurality of transducers positioned substantially parallel to the flow direction along the wall of the conduit. The system includes means for modeling the superposition of a plurality of sound waves as they propagate within the conduit.Type: GrantFiled: March 14, 2013Date of Patent: September 13, 2016Assignee: The Board of Regents of the University System of GeorgiaInventor: Kenneth Charles McGill, Sr.
-
Publication number: 20160135435Abstract: Many types of artificial reefs have been deployed in the world's oceans, bays and estuaries. These range from sinking ships to dispersing old building debris. In most approaches, the material placed in the marine environment lacks any nutrients needed for growth or concern regarding proper chemical conditions necessary to start and sustain life. In this discovery, concrete is made from both inorganic and organic components. The inorganic components are selected to include species that will be used to create a receptive surface to start and sustain life. Moreover, other conditions such as pH, chemical toxicity, nutrient levels and biodegradability are considered in the formulation. Additionally, there is an organic component that is part of the concentration mixture which provides trace nutrients and serves to weaken the structures so it will biodegrade over time. The biodegradable concrete slowly releases small quantities of resources (over months and years) providing a steady flux of essential nutrients.Type: ApplicationFiled: November 13, 2014Publication date: May 19, 2016Applicant: Valdosta State University, University System of GeorgiaInventors: Thomas Manning, Brittany Butler, Mehulkumar Patel, Sydney Plummer, Tess Baker
-
Publication number: 20160038422Abstract: Bacterial resistance to antibiotics is increasing worldwide creating a global threat. Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, is a bacterial infectious disease that results in over one million deaths annually. The discovery outlined here involves a tablet composition for patient administration and subsequently a new paradigm in drug delivery vehicles in vivo and in vitro and is applied to existing TB antibiotics in order to increase their efficacy. The drug delivery system is a three component complex that is administered with the TB antibiotic or a combination of TB antibiotics. The components are a saccharide or saccharides, a transition metal ion or a combination of metal ions that can bind a nitrogen and/or oxygen atom(s), and a water soluble polymer capable of aggregating and enclosing the other constituents. The three component molecular delivery approach has demonstrated ability to overcome M. tuberculosis bacterial resistance to an existing antibiotic.Type: ApplicationFiled: August 3, 2015Publication date: February 11, 2016Applicant: University System of Georgia, Valdosta State UniversityInventors: Thomas J. Manning, Sydney E. B. Plummer, Tess A. Baker
-
Publication number: 20130237511Abstract: Methods for utilizing copper ions to bind to and help transport medicinal agents that contain a nitrogen atom or atoms are disclosed. The copper ion or ions serve as a delivery platform for a known pharmaceutical agent. The copper ions may be used to impact the polarity of the medicinal agents so they perform more efficiently in a physiological environment. The copper ions may also improve the efficacy of the drug by impacting their stability.Type: ApplicationFiled: March 12, 2012Publication date: September 12, 2013Applicants: University System of Georgia, Valdosta State UniversityInventors: Thomas J. Manning, Ryenne Nicole Ogburn, Kaitlyn Victoria Ledwitch, Dennis Ray Phillips, Gregory Page Wylie
-
Publication number: 20130004993Abstract: Methods for producing and obtaining natural products from microbial amplification chambers are described. This approach utilizes the concept of green chemistry to synthesize and extract the marine and terrestrial natural products. The method describes techniques to colonize and grow the selected bacteria and to continuously harvest the pharmaceutical agent from the broth without using any commercial solvents.Type: ApplicationFiled: June 28, 2011Publication date: January 3, 2013Applicants: University System of Georgia, Valdosta State UniversityInventor: Thomas J. Manning